Edaravone

Chemical compound

Edaravone, sold under the brand name Radicava among others, is a medication used to treat stroke and amyotrophic lateral sclerosis (ALS). It is given by intravenous infusion and by mouth. The mechanism by which edaravone might be effective is unknown.

Nº Q335099 ★

Common · Knowledge

Edaravone

Chemical compound

Edaravone, sold under the brand name Radicava among others, is a medication used to treat stroke and amyotrophic lateral sclerosis (ALS). It is given by intravenous infusion and by mouth. The mechanism by which edaravone might be effective is unknown.

Last price

—

Floor price

—

7-day median

—

30-day sales

0

30-day range

—

In circulation

0

Price history

Show table
Datemedian LowHighsales

Sales history

Last sale
—
30-day average
—
30-day low
—
30-day high
—
Sales 7d
0
Sales 30d
0

No sales yet.

Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.

From Wikipedia

Edaravone, sold under the brand name Radicava among others, is a medication used to treat stroke and amyotrophic lateral sclerosis (ALS). It is given by intravenous infusion and by mouth. The mechanism by which edaravone might be effective is unknown. The medication is known to be an antioxidant, and oxidative stress has been hypothesized to be part of the process that kills neurons in people with ALS and in stroke victims. The most common side effects include bruising (contusions), problems walking (gait disturbances), and headaches. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.

Text: Wikipédia, CC BY-SA 4.0. · Image: Jü (Public domain) ·

Related cards

View card

Confirmation